FDA — authorised 18 July 1978
- Application: NDA017820
- Marketing authorisation holder: LILLY
- Local brand name: DOBUTREX
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Dobutrex on 18 July 1978
Yes. FDA authorised it on 18 July 1978.
LILLY holds the US marketing authorisation.